tirzepatide original name FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price New Blockbuster Type 2 Medication

WEGOVY (Semaglutide) Prescribing Information (US Food and Drug Administration, 2022)

Personalization: Genetic Testing Reveals Your Semaglutide Response Potential The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) variants that relate to GLP-1 and related signaling pathways

Compounded GLP-1 from licensed 503A pharmacies offers an alternative for patients seeking faster access or lower costs

Combining glucose metabolic regulation with other therapies Aberrant glucose metabolism is a hallmark of tumors, contributing to immune evasion, rapid proliferation, and therapeutic resistance